Dallas Morning News on MSN1 天
FDA adds new warning to weight loss drugs including Wegovy
The FDA added the warning to most of the drugs on Nov. 1, according to the agency’s website. The warning applies to GLP-1 ...
WebMD1 天
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
Onlymyhealth12 小时
FDA Issues New Warning For Popular Weight Loss Drugs—Here's What You Need To Know
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...
FDA recalls nearly 80,000 pounds of butter from Costco stores in Texas. Here's what to ...
The U.S. Food and Drug Administration's recall concerns two butter products produced by Continental Dairy ...
Supplement Recalls: FDA Warns of Products With 'Hidden Drug Ingredient'
The FDA warned that VitalityXtra and PeakMax ... Two dietary supplements have been recalled after "hidden" drugs were found inside them that were not listed on the label. A man pours pills onto his ...
Medscape2 天
Introduction to the New Prescription Drug Labeling by the Food and Drug Administration
A separate section on patient-counseling information has been added in response to the requirement that all FDA-approved patient information be reprinted in or accompany drug product labeling.
dvm36014 天
FDA: Off-label use of aspirin in lactating dairy cattle is prohibited
Vazalore is currently the only FDA-approved human aspirin that may be used in food-producing animals under certain conditions ...
Organon updates outlook as FDA delays VTAMA label expansion
Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...
Medscape7 天
Introduction to the New Prescription Drug Labeling by the Food and Drug Administration
Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...
US FDA approves Journey Medical's drug for long-term skin condition
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...
Zacks.com on MSN21 天
Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz
Avadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking ...
Yahoo Finance21 天
Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz
Avadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking label expansion of Lumryz. The drug is now approved in the United States ...